GOSS
Gossamer Bio Inc

2,514
Loading...
Loading...
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
145

Frequently Asked Questions

What is Market Cap of Gossamer Bio Inc?
What is the 52-week high for Gossamer Bio Inc?
What is the 52-week low for Gossamer Bio Inc?
What is Gossamer Bio Inc stock price today?
What was Gossamer Bio Inc stock price yesterday?
What is the PE ratio of Gossamer Bio Inc?
What is the Price-to-Book ratio of Gossamer Bio Inc?
What is the 50-day moving average of Gossamer Bio Inc?
How many employess does Gossamer Bio Inc has?

Latest GOSS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.